Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services comprising screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order, specialty and compounding pharmacy, and infertility treatment services, as well as drug benefits under the federal government's Medicare Part D program. As of April 12, 2018, the company operated approximately 2,548 stores in 19 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
Phone717-761-2633
Debt
Current Ratio1.59
Quick Ratio0.90
Price-To-Earnings
Sales & Book Value
Annual Sales$21.53 billion
Price / Sales0.04
Price / Cash Flow1.38
Price / Book0.65
Profitability
Net Income$943.47 million
Net Margins2.85%
Return on Assets-0.18%
Miscellaneous
Employees59,000
OptionableOptionable
Rite Aid (NYSE:RAD) Frequently Asked Questions
What is Rite Aid's stock symbol?
Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."
How were Rite Aid's earnings last quarter?
Rite Aid Co. (NYSE:RAD) issued its earnings results on Wednesday, December, 19th. The company reported $0.01 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.01) by $0.02. The business had revenue of $5.45 billion for the quarter, compared to analysts' expectations of $5.45 billion. Rite Aid had a negative return on equity of 0.94% and a net margin of 2.85%. The firm's quarterly revenue was up 1.8% on a year-over-year basis. View Rite Aid's Earnings History.
When is Rite Aid's next earnings date?
What guidance has Rite Aid issued on next quarter's earnings?
Rite Aid updated its FY19 earnings guidance on Wednesday, December, 19th. The company provided earnings per share guidance of ($0.03)-($0.01) for the period, compared to the Thomson Reuters consensus estimate of $0.00. The company issued revenue guidance of $21.8-$21.95 billion, compared to the consensus revenue estimate of $21.80 billion.Rite Aid also updated its FY 2019 guidance to $-0.03--0.01 EPS.
What price target have analysts set for RAD?
5 Wall Street analysts have issued 12 month price targets for Rite Aid's stock. Their predictions range from $1.00 to $6.00. On average, they expect Rite Aid's share price to reach $2.20 in the next twelve months. This suggests a possible upside of 147.2% from the stock's current price. View Analyst Price Targets for Rite Aid.
What is the consensus analysts' recommendation for Rite Aid?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 1 sell rating and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Rite Aid.
Has Rite Aid been receiving favorable news coverage?
Headlines about RAD stock have trended positive recently, according to InfoTrie. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Rite Aid earned a coverage optimism score of 2.8 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 7.0 out of 10, meaning that recent media coverage is likely to have an effect on the company's share price in the next several days.
Are investors shorting Rite Aid?
Rite Aid saw a decrease in short interest in the month of December. As of December 31st, there was short interest totalling 107,364,070 shares, a decrease of 5.5% from the December 14th total of 113,620,310 shares. Based on an average daily volume of 24,271,324 shares, the days-to-cover ratio is currently 4.4 days. Approximately 10.2% of the company's stock are sold short. View Rite Aid's Current Options Chain.
Who are some of Rite Aid's key competitors?
Who are Rite Aid's key executives?
Rite Aid's management team includes the folowing people:
- Mr. John T. Standley, CEO & Director (Age 56)
- Mr. Kermit Ray Crawford, Pres & COO (Age 60)
- Mr. Darren Wayne Karst, Sr. EVP, CFO & Chief Admin. Officer (Age 59)
- Ms. Jocelyn Zazyczny Konrad, Exec. VP of Pharmacy (Age 49)
- Mr. Bryan B. Everett, Chief Operating Officer of Rite Aid Stores (Age 46)
Who are Rite Aid's major shareholders?
Which major investors are buying Rite Aid stock?
How do I buy shares of Rite Aid?
Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rite Aid's stock price today?
One share of RAD stock can currently be purchased for approximately $0.89.
How big of a company is Rite Aid?
Rite Aid has a market capitalization of $865.88 million and generates $21.53 billion in revenue each year. The company earns $943.47 million in net income (profit) each year or ($0.02) on an earnings per share basis. Rite Aid employs 59,000 workers across the globe.
What is Rite Aid's official website?
How can I contact Rite Aid?
Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17011. The company can be reached via phone at 717-761-2633 or via email at [email protected]
MarketBeat Community Rating for Rite Aid (NYSE RAD)
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
